$OPEN: Why the SRXH Investment into $OPEN Changes the Thesis ?

AI Summary

Author is long Opendoor Technologies ($OPEN) citing SRx Health Solutions' treasury investment, CEO-led turnaround, and potential short squeeze toward $10.

OPEN — LONG Author is long Opendoor Technologies, arguing that SRx Health Solutions' treasury purchase of OPEN validates the stock and could trigger a retail-driven short squeeze toward $10. The bull case also rests on CEO Kaz Nejatian's "Opendoor 2.0" strategy, which focuses on high volume, lower spreads, and AI-driven cost-cutting, plus macro relief from a $200B mortgage bond plan that could break housing gridlock. The author states that if inventory moves, $OPEN wins, but provides no explicit time horizon beyond the possible squeeze toward $10.

Institutional/Corporate Validation: When other public companies start using their treasury to buy your stock, it usually means they see a bottom or a massive undervalued asset.

Score 3

Comments 2

▶ Full Post Text

I’ve been watching Opendoor Technologies ($OPEN) closely after its insane 260% run-up in 2025, and today we just got a weird but potentially massive catalyst.

SRx Health Solutions ($SRXH) just announced they are deploying excess liquidity into $OPEN common stock. This isn't just a random buy; $SRXH has been aggressive with their capital allocation lately (Bitcoin, Ethereum, etc.), and adding $OPEN to their "treasury strategy" puts a fresh spotlight on the stock’s current valuation.

The Quick Rundown:

• The News: SRx Health Solutions ($SRXH) officially invested in $OPEN common stock as of January 16, 2026.

• Current Price Action: $OPEN is currently hovering around the $6.30 - $6.50 range. It’s been cooling off from its late 2025 "meme-style" highs, but it's still holding way above the $0.50 lows we saw last summer.

• The "New" Opendoor: Since Kaz Nejatian (former Shopify COO) took over as CEO, the focus has shifted entirely to "Opendoor 2.0"—high volume, lower spreads, and AI-driven cost-cutting.

Why this matters?

While $OPEN technically graduated from "penny" status during its 2025 rally, many of us played it when it was sub-$1.00. Here is why the $SRXH news is a signal:

1. Institutional/Corporate Validation: When other public companies start using their treasury to buy your stock, it usually means they see a bottom or a massive undervalued asset.

2. Short Interest & Momentum: We saw what happened in 2025 when Reddit and X caught wind of the turnaround—the stock moved 13x from its lows. If $SRXH's entry triggers another retail wave, we could see a squeeze back toward the $10 mark.

3. Macro Tailwinds: With the administration's recent focus on the $200B mortgage bond plan, the "housing gridlock" might finally be breaking. If inventory moves, $OPEN wins.

Bottom Line: $OPEN is no longer just a "struggling iBuyer." It’s becoming a tech-heavy turnaround play with corporate backing. 

Disclaimer: Not financial advice. I am long $OPEN. Do your own DD.

Ideas

u/Impossible-Hair1343 Reddit r/pennystocks

Long OPEN on SRXH validation, CEO turnaround, squeeze to $10.

Author is long Opendoor Technologies, arguing that SRx Health Solutions' treasury purchase of OPEN validates the stock and could trigger a retail-driven short squeeze toward $10. The bull case also rests on CEO Kaz Nejatian's "Opendoor 2.0" strategy, which focuses on high volume, lower spreads, and AI-driven cost-cutting, plus macro relief from a $200B mortgage bond plan that could break housing gridlock. The author states that if inventory moves, $OPEN wins, but provides no explicit time horizon beyond the possible squeeze toward $10.

▶ Full Post Text

Ideas

More from Reddit — r/pennystocks